Application 040378
- Type
- ANDA
- Sponsor
- AVONDALE PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NIACOR | NIACIN | TABLET;ORAL | 500MG | No | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A040378-001 | NIACOR | NIACIN | 500MG | TABLET / ORAL | RS | 2000-05-03 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A040378-001 | NIACOR | 500MG | TABLET / ORAL | RS | 2000-05-03 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A040378-001 | NIACOR | 500MG | TABLET / ORAL | RS | 2000-05-03 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A040378-001 | NIACOR | 500MG | TABLET / ORAL | RS | 2000-05-03 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A040378-001 | NIACOR | 500MG | TABLET / ORAL | RS | 2000-05-03 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A040378-001 | AA | 1 | 74a2ff9319b5… |
| 2020-11-12 02:37 UTC | 2020-11 | A040378-001 | AA | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A040378-001 | AA | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A040378-001 | AA | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A040378-001 | AA | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Niacin | NIACIN | Redmont Pharmaceuticals, LLC | f51f7e6d-b132-48d8-8bb1-54203472f0d8 | 2025-12-17 | Warnings, Adverse reactions | 040378 ANDA040378 71741-020 |
| Niacor | NIACIN | Avondale Pharmaceuticals, LLC | bf287412-160b-403f-8eb4-57f29a475902 | 2021-12-23 | Warnings, Adverse reactions | 040378 ANDA040378 71740-001 |
| Niacin | NIACIN | Emerald Therapeutics, LLC | 5fceeb58-e54d-43c1-8abb-33feea69d663 | 2021-04-07 | Warnings, Adverse reactions | 040378 ANDA040378 72919-420 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0245-0067 | Niacor | Niacin | Upsher-Smith Laboratories, LLC | ANDA | Current |
| 0245-0067 | Niacor | Niacin | Upsher-Smith Laboratories, LLC | ANDA | Current |
| 71740-001 | Niacor | Niacin | Avondale Pharmaceuticals, LLC | ANDA | Current |
| 71740-201 | Niacor | niacin | Avondale Pharmaceuticals, LLC | ANDA | Current |
| 71740-201 | Niacor | niacin | Avondale Pharmaceuticals, LLC | ANDA | Current |
| 71741-020 | Niacin | Niacin | Redmont Pharmaceuticals, LLC | ANDA | Current |
| 71741-047 | NIACIN | NIACIN | Redmont Pharmaceuticals, LLC | ANDA | Current |
| 72919-420 | Niacin | Niacin | Emerald Therapeutics, LLC | ANDA | Current |